BackBioton S.a. Overview

Bioton S.a. Profit Margin

Valuation check: BIO.WA's profit margin is -4.62%, below the Healthcare sector average of 17.63%.

Get informed when a big investor buys or sells

+ Follow

Quarterly Profit Margin

1.60%
↓ 72.32% YoY

As of Sep 2026

Annual Profit Margin (TTM)

-4.62%
↓ 383.82% YoY

Trailing 12 months ending Sep 2026

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading

Bioton S.a. (BIO.WA) FAQ

Bioton S.a. (BIO.WA) currently reports a profit margin of -4.62% as of September 2026. That compares with -0.95% in the prior-year period — down 383.8% year over year. That is below the Healthcare sector average of 17.63%. Use the charts on this page to explore Bioton S.a.'s profit margin history and peer comparisons.

Bioton S.a.'s profit margin decreased from -0.95% to -4.62% — a 383.8% year-over-year decrease (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Bioton S.a.'s profit margin of -4.62% is lower than the Healthcare sector average of 17.63%. That is roughly 126.2% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Bioton S.a.'s current -4.62% should be judged against Healthcare norms (sector average: 17.63%) and against BIO.WA's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -4.62%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 17.63%. From there, open related valuation or income-statement pages for Bioton S.a., and consider following BIO.WA for alerts when major investors trade the stock.